Table 2.
Grade 3–4 Toxicities and Adverse Events
| Inpatient (%) | Outpatient (%) | P Value | |
|---|---|---|---|
| Total Toxicities | 1.000 | ||
| 0 | 96 (71.1) | 67 (70.5) | |
| 1 | 30 (22.2) | 22 (23.2) | |
| 2 | 5 (3.7) | 4 (4.2) | |
| 3 | 4 (3.0) | 2 (2.1) | |
| Diarrhea | 15 (11.1) | 14 (14.7) | 0.415 |
| Afib | 8 (5.9) | 1 (1.1) | 0.085 |
| Mucositis | 8 (5.9) | 6 (6.3) | 0.907 |
| HTN | 2 (1.5) | 3 (3.2) | 0.651 |
| CVL Complications | 0.545 | ||
| DVT | 9 (6.7) | 8 (8.4) | |
| Infection | 5 (3.7) | 1 (1.1) | |
| Revisions | 1 (0.7) | 0 (0.0) | |
| Febrile Neutropenia | 45 (33.6) | 28 (29.5) | 0.635 |
| Infections | 27 (20.0) | 18 (18.9) | 0.843 |
| C diff | 0.782 | ||
| Yes(any) | 16 (11.6) | 8 (8.4) | |
| New | 14 (10.4) | 7 (7.4) | |
| Reactivated | 2 (1.5) | 1 (1.1) | |
| Positive Blood Cx | 13 (9.6) | 9 (9.5) | 0.968 |
| Engraftment Syndrome | 31 (23.0) | 19 (20.0) | 0.592 |
| Total Unplanned Admits | <0.001 | ||
| 0 | 120 (88.9) | 62 (65.3) | |
| 1 | 11 (8.1) | 24 (25.3) | |
| 2 | 3 (2.2) | 8 (8.4) | |
| 3 | 1 (0.7) | 1 (1.1) |